Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways

Abstract

Hepatocyte growth factor (HGF) regulates various physiological and developmental processes in concert with other growth factors, cytokines and hormones. We examined interactions between cell signaling events elicited by HGF and the cytokine interleukin (IL)-4, in the IL-3-dependent murine myeloid cell line 32D transfected with the human HGF receptor, c-Met. HGF was a potent mitogen in these cells, and prevented apoptosis in response to IL-3 withdrawal. IL-4 showed modest anti-apoptotic activity, but no significant mitogenic activity. IL-4 synergistically enhanced HGF-stimulated DNA synthesis, whereas only additive prevention of apoptosis was observed. IL-4 did not enhance HGF-dependent tyrosine phosphorylation of c-Met or Shc. In contrast, HGF-stimulated activation of MAP kinases was enhanced by IL-4, suggesting that the IL-4 and HGF signaling pathways converge upstream of these events. Although phosphatidylinositol 3-kinase (PI3K) inhibitors diminished HGF-induced mitogenesis, anti-apoptosis, and MAP kinase activation, IL-4 enhanced HGF signaling persisted even in the presence of these inhibitors. IL-4 enhancement of HGF signaling was partially blocked in 32D/c-Met cells treated with inhibitors of MEK1 or c-Src kinases, completely blocked by expression of a catalytically inactive mutant of Janus kinase 3 (Jak3), and increased in 32D/c-Met cells overexpressing STAT6. Our results suggest that the IL-4 and HGF pathways converge at multiple levels, and that IL-4-dependent Jak3 and STAT6 activities modulate signaling events independent of PI3K to enhance HGF-dependent mitogenesis in myeloid cells, and possibly other common cellular targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adams DH, Harvath L, Bottaro DP, Interrante R, Catalano G, Tanaka Y, Strain A, Hubscher SG, Shaw S . 1994 Proc. Natl. Acad. Sci. USA 91: 7144–7148

  • Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR . 1995 J. Biol. Chem. 270: 27489–27494

  • Balkovetz DF, Lipschutz JH . 1999 Int. Rev. Cytol. 186: 225–260

  • Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM, Ponzetto C . 1992 Oncogene 7: 1973–1978

  • Birchmeier C, Gherardi E . 1998 Trends Cell. Biol. 8: 404–410

  • Birchmeier W, Brinkmann V, Niemann C, Meiners S, DiCesare S, Naundorf H, Sachs M . 1997 Ciba Found Symp. 212: 230–240

  • Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM . 1998 Nature 391: 285–287

  • Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG . 1996 TIBS 21: 257–261

  • Borset M, Seidel C, Hjorth-Hansen H, Waage A, Sundan A . 1999 Leuk. Lymphoma 32: 249–256

  • Chan AML, Rubin JS, Bottaro DP, Hirschfield DW, Chedid M, Aaronson SA . 1991 Science 254: 1382–1385

  • Cioce V, Czaky KG, Chan AML, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS . 1996 J. Biol. Chem. 271: 13110–13115

  • Cosman D . 1993 Cytokine 5: 95–106

  • Cowley S, Paterson H, Kemp P, Marshall CJ . 1994 Cell 77: 841–852

  • Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP . 1999 Oncogene 18: 3399–3406

  • Delaney B, Koh WS, Yang KH, Strom SC, Kaminski NE . 1993 Life Sci. 53: PL89–PL93

  • Gandino L, Longati P, Medico E, Prat M, Comoglio PM . 1994 J. Biol. Chem. 269: 1815–1820

  • Gohda E, Nakamura S, Yamamoto I, Minowada J . 1995 Leuk. Lymphoma 19: 197–205

  • Graziani A, Gramaglia D, dalla Zonca P, Cantley LC, Comoglio PM . 1991 J. Biol. Chem. 266: 22087–22090

  • Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA . 1996 J. Biol. Chem. 271: 695–701

  • Hassuneh MR, Nagarkatti PS, Nagarkatti M . 1997 Blood 89: 610–620

  • Hoon DSB, Okun BE, Banez M, Irie FR, Morton DL . 1991 Cancer Res. 51: 5687–5693

  • Iguchi T, Sogo S, Hisha H, Taketani S, Adachi Y, Miyazaki R, Ogata H, Masuda S, Sasaki R, Ito M, Fukuhara S, Ikehara S . 1999 Stem Cells 17: 82–91

  • Ikehara S . 1996 Leuk. Lymphoma 20: 297–303

  • Ikizawa K, Kajiwara K, Koshio T, Yanagihara Y . 1994 J. Allergy Clin. Immunol. 94: 620–624

  • Kaplan MH, Daniel C, Schindler U, Grusby KJ . 1998 Mol. Cell. Biol. 18: 1996–

  • Keegan AD, Nelms K, Wang L-M, Pierce JH, Paul WE . 1994 Immunol. Today 15: 423–432

  • Kmiecik TE, Keller JR, Rosen E, Vande Woude GF . 1992 Blood 80: 2454–2457

  • Machide M, Kamitori K, Nakamura Y, Kohsaka S . 1998 J. Neurochem. 71: 592–602

  • Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG . 1994 Science 265: 966–970

  • Michalopoulos GK, DeFrances MC . 1997 Science 276: 60–66

  • Montesano R, Soriano JV, Malinda KM, Ponce LM, Kleinman HK, Bafico A, Bottaro DP, Aaronson SA . 1998 Cell. Growth Diff. 9: 355–365

  • Morisaki T, Yuzuki DH, Lin RT, Foshag LJ, Morton DL, Hoon DSB . 1992 Cancer Res. 52: 6059–6065

  • Morisaki T, Uchiyama A, Yuzuki DH, Essner R, Morton DL, Hoon DSB . 1994 Cancer Res. 54: 1113–1118

  • Patel BKR, Wang L-M, Lee C-C, Taylor WG, Pierce JH, LaRochelle WJ . 1996 J. Biol. Chem. 271: 22175–22182

  • Paul WE . 1991 Blood 77: 1859–1870

  • Pierce JH, Ruggiero M, Fleming TP, Di Fiore PP, Greenberger JS, Varticovski L, Schlessinger J, Rovera G, Aaronson SA . 1988 Science 239: 628–631

  • Postlethwaite AE, Holness MA, Katai H, Raghow R . 1992 J. Clin. Invest. 90: 1479–1485

  • Postlethwaite AE, Seyer JM . 1991 J. Clin. Invest. 87: 2147–2152

  • Rahimi N, Tremblay E, Elliott B . 1996 J. Biol. Chem. 271: 24850–24855

  • Rubin JS, Bottaro DP, Aaronson SA . 1993 Biochim. Biophys. Acta. 1155: 357–371

  • Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS . 1997 J. Biol. Chem. 272: 9457–9463

  • Schwall RH, Chang LY, Kahn DW, Hillan KJ, Bauer KD, Zioncheck TF . 1996 J. Cell. Biol. 133: 709–718

  • Schaper F, Siewert E, Gomez-Lechon MJ, Gatsios P, Sachs M, Birchmeier W, Heinrich PC, Castell J . 1997 FEBS Lett. 405: 99–103

  • Soon L, Flechner L, Gutkind JS, Wang LH, Baserga R, Pierce JH, Li W . 1999 Mol. Cell. Biol. 38: 16–28

  • Stahl SJ, Wingfield PT, Kaufman JD, Pannell LK, Cioce V, Sakata H, Taylor WG, Rubin JS, Bottaro DP . 1997 Biochem. J. 326: 763–772

  • Streit AC, Stern CD . 1997 Ciba. Found. Symp. 212: 155–165

  • Sunitha I, Shen R, McKillop IH, Lee JH, Resau J, Avigan M . 1999 Exp. Cell. Res. 250: 86–98

  • Torigoe T, O'Connor R, Santoli D, Reed JC . 1992 Blood 80: 617–624

  • Uchiyama A, Essner R, Doi F, Nguyen T, Ramming KP, Nakamura T, Morton DL, Hoon DSB . 1996 J. Cell. Biochem. 62: 443–453

  • Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J . 1997 Ciba. Found. Symp. 212: 119–130

  • van Dijk M, Muriana FJ, van Der Hoeven PC, de Widt J, Schaap D, Moolenaar WH, van Blitterswijk WJ . 1997 Biochem. J. 323: 693–699

  • Wang L-M, Keegan AD, Paul WE, Heidaran MA, Gutkind JS, Pierce JH . 1992 EMBO J. 11: 4899–4908

  • Wang L-M, Myers Jr MG, Sun X-J, Aaronson SA, White MF, Pierce JH . 1993 Science 261: 1591–1594

  • Weimar IS, de Jong D, Muller EJ, Nakamura T, van Gorp JM, de Gast GC, Gerritsen WR . 1997 Blood 89: 990–1000

  • Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR . 1998 Exp. Hematol. 9: 885–894

  • Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN . 1994 Nature 370: 153–157

  • Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T . 1993 J. Biol. Chem. 268: 21212–21217

  • Yashiro M, Chung Y-S, Inoue T, Nichimura S, Matsuoka T, Fukihara T, Sowa M . 1996 Int. J. Cancer 67: 289–293

  • Yu CZ, Hisha H, Li Y, Lian Z, Nishino T, Toki J, Adachi Y, Inaba M, Fan TX, Jin T, Iguchi T, Sogo S, Hosaka N, Song TH, Xing J, Ikehara S . 1998 Stem Cells 16: 66–77

  • Zamorano J, Wang HY, Wang L-M, Pierce JH, Keegan AD . 1996 J. Immunol. 157: 4926–4934

  • Zarnegar R, Michalopoulos GK . 1995 J. Cell. Biol. 129: 1177–1180

Download references

Acknowledgements

We thank Drs Jacalyn Pierce, Jeffrey Rubin, William Taylor, William LaRochelle, and Yuichiro Suzuki for helpful discussions. We also thank Nelson Ellmore for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald P Bottaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, R., Soon, L., Breckenridge, D. et al. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene 21, 2201–2211 (2002). https://doi.org/10.1038/sj.onc.1205289

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205289

Keywords

This article is cited by

Search

Quick links